Contact

For the following products:


ALKERAN® (melphalan)
ELTROXIN® (levothyroxine)
IMURAN® (azathioprine)
LANVIS® (tioguanine)
LEUKERAN® (chlorambucil)
MYLERAN® (busulfan)
SEPTRA® (sulfamethoxazole, trimethoprim)







Email: Info@aspripharma.com
Phone: 1-855-868-8440
Fax : 514-868-8437
For the following products:


Bellergal® Spacetabs
Oesclim®
Estragyn
Osto-D2®
Dermaflex HC 1%
Topiderm HC 2%
Veregen®
Monurol®
Dermaflex®-20
Cysta-QTM
Q-UrolTM



Email: medinfo@paladinlabs.com
Phone: 1-888-867-7426
Fax : 514-340-0164






Don’t throw them out, visit www.medicationsreturn.ca

Prescription products

News

PUBLIC COMMUNICATION 26 March 2014

DEAR HCP LETTER 26 March 2014

VEREGEN - Approval in Canada 12 September 2013

MediGene and Triton Pharma Sign Partnership Agreement for the Commercialization of Veregen® in Canada May 2, 2011

MONTREAL, April 28 /CNW Telbec/ - The biotech company MediGene AG (Frankfurt, Prime Standard) has signed an exclusive license and supply agreement with the Canadian company Triton Pharma Inc....

Vaniqa - the new topical treatment that slows the growth of unwanted facial hair in women August 2, 2010

TORONTO, July 19 /CNW/ - Triton Pharma Inc. announces the launch of VANIQA(R), the only topical prescription treatment cream that slows the growth of facial hair in women.

To view the...